| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Jounce Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-09 | Opaleye Management Inc. | Jounce Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-02 | Cowen Financial Products LLC | Jounce Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-05-05 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 10,000 | 100.0% | EDGAR |
| SC 13G | 2023-04-12 | Opaleye Management Inc. | Jounce Therapeutics, Inc. | 2,810,000 | 5.4% | EDGAR |
| SC 13D/A | 2023-04-07 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 5,300,087 | 10.2% | EDGAR |
| SC 13D/A | 2023-03-28 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 5,300,087 | 10.2% | EDGAR |
| SC 13D/A | 2023-03-17 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 5,300,087 | 10.2% | EDGAR |
| SC 13D | 2023-03-14 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 5,300,087 | 10.2% | EDGAR |
| SC 13G | 2023-03-06 | TANG CAPITAL PARTNERS LP | Jounce Therapeutics, Inc. | 5,000,000 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | Jounce Therapeutics, Inc. | 5,106,341 | 9.9% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED ADVISORS LLC | Jounce Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | PFM Health Sciences, LP | Jounce Therapeutics, Inc. | - | 0.7% | EDGAR |
| SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Jounce Therapeutics, Inc. | 4,259,653 | 8.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Third Rock Ventures II, L.P. | Jounce Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-14 | BANK OF AMERICA CORP /DE/ | Jounce Therapeutics, Inc. | 3,276,699 | 6.3% | EDGAR |
| SC 13G/A | 2023-01-23 | Cowen Financial Products LLC | Jounce Therapeutics, Inc. | 3,647,430 | 7.0% | EDGAR |
| SC 13G | 2022-04-22 | Cowen Financial Products LLC | Jounce Therapeutics, Inc. | 3,080,352 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-14 | PFM Health Sciences, LP | Jounce Therapeutics, Inc. | - | 7.8% | EDGAR |
| SC 13G/A | 2022-02-14 | Deep Track Capital, LP | Jounce Therapeutics, Inc. | 4,000,000 | 7.8% | EDGAR |